Biden Administration Releases Policy To Seize Drug Patents Based On Price

The Biden team has released a plan for federal officials to use "march-in rights" to seize the patents of drugs they deem overpriced.

Related Keywords

France ,Canada ,Australia ,United States ,White House ,District Of Columbia ,America ,American ,Fred Ledley ,Ekaterina Cleary ,George Soros ,Matthew Jackson ,Institute For New Economic ,Bentley University ,National Institutes Of Health ,Government Accountability Office ,Bloomberg ,Accountability Office ,New Economic Thinking ,National Institutes ,Pharmaceutical Research ,Us ,Pharmaceuticals ,Biden Administration ,Trump Administration ,Skyrocketing Drug Costs ,Nih ,